Skip to main content
OpenTrials
Completed

NCT Number: NCT03076645

Measure of Engagement of Epilepsy Patients in Messaging Groups

This study will measure the engagement of people with epilepsy in a mobile phone based messaging platform as well as understand if there is an impact on their self-management

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Epilepsy Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lewisham & Greenwich NHS Trust, Lewisham, United Kingdom

Loading trial locations.

About this study

The primary purpose of this study is to assess a person with epilepsy's level of usage of a mobile messaging application for peer support. The secondary purpose is to understand what characteristics of their group drive different levels of usage and improvements in self-management.

Participants can participate as much or little as they want for a minimum of six weeks. Participants will complete an initial and a final questionnaire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age, diagnosis of epilepsy, have access to a smartphone capable of running messaging application

Exclusion criteria

  • A diagnosis of learning disability/difficulty, significant mental health conditions; those in care, bereaved, or prisoners. Any other vulnerable individuals (individuals unable to protect themselves against significant harm or exploitation)

Treatment and study plan

Facilitator support and education

Behavioral

Group engaged with facilitator support and education

Primary outcomes

  1. Engagement

    Time frame: 6 weeks

    Average participant number of posts over time frame assessed by tracking number of participant entries

Secondary outcomes

  1. Epilepsy self-management

    Time frame: Change in Baseline to 6 weeks

    Patient activation measure based on self-reported questionnaire

  2. Epilepsy medication adherence

    Time frame: Change in Baseline to 6 weeks

    Medication adherence based on self-reported questionnaire

  3. Epilepsy quality of life

    Time frame: Change in Baseline to 6 weeks

    Quality of life in epilepsy metric based on self-reported questionnaire

Sponsors and collaborators

Lead sponsor

Royal Free Hospital NHS Foundation Trust

Other

Registry information

Official study title

Measure of Engagement of Epilepsy Patients in Messaging Groups and Group Characteristics That Influence Engagement.

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Mar 10, 2017
Registry last updated
Oct 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.